Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Liver Int. 2018 Dec 28;39(5):826–834. doi: 10.1111/liv.14014

Figure 3.

Figure 3.

Time to HCV negativity and predicted time to cure based on Child-Turcotte-Pugh (CTP) or liver stiffness measurement (LSM). (A) Proportion of patients who achieved target not detected (TND), and predicted to achieve extracellular body fluid (CL-EF) and HCV-infected hepatocytes clearance (CL-C) at specific time points during the treatment, comparing those with CTP≤B7 and those with CTP>B7. (B) Proportion of patients who achieved TND, CL-EF and CL-C at specific time points during the treatment, comparing those with LSM>21 kPa and those with LSM≥21kPa.